BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108063
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108063
Table 2 Encounter diagnoses and procedures, and disposition by sex, n (%)
Attribute
Overall (n = 1386)
Male (n = 875)
Female (n = 511)
P value
Diagnoses
Ascites1009 (72.8)365 (71.4)644 (73.6)0.3808
Bacteremia89 (6.4)62 (7.1)27 (5.3)0.1867
Clostridium difficile infection61 (4.4)35 (4)26 (5.1)0.3407
Esophageal variceal bleed121 (8.7)96 (11)25 (4.9)0.0001b
Hepatic encephalopathy575 (41.5)376 (43)199 (38.9)0.1420
Hepatorenal syndrome231 (16.7)158 (18.1)73 (14.3)0.0691
Pneumonia234 (16.9)138 (15.8)96 (18.8)0.1483
Portal vein thrombosis55 (4)40 (4.6)15 (2.9)0.1323
Spontaneous bacterial peritonitis1 (0.1)01 (0.1)0.4447
Sepsis291 (21)167 (19.1)124 (24.3)0.0223a
Substance/alcohol use disorder1075 (77.6)687 (78.5)388 (75.9)0.2658
Urinary tract infection271 (19.6)122 (13.9)149 (29.2)< 0.0001b
Medications:
Use of any vasopressors235 (17)137 (15.7)98 (19.2)0.0919
Norepinephrine227 (16.4)130 (14.9)97 (19)0.0453a
Epinephrine58 (4.2)39 (4.5)19 (3.7)0.5074
Vasopressin118 (8.5)65 (7.4)53 (10.4)0.0582
Use of steroids503 (36.3)328 (37.5)175 (34.3)0.2263
Use of N-acetylcysteine137 (9.9)82 (9.4)55 (10.8)0.4023
Procedures:
Renal replacement therapy36 (2.6)18 (2.1)18 (3.5)0.0980
Hemodialysis10 (0.7)8 (0.9)2 (0.4)0.2671
Mechanical ventilation252 (18.2)149 (17)103 (10.8)0.1452
Length of stay (days)
    Median5.65.55.70.4989
    Range0.1-92.70.1-92.70.1-75.7
Disposition
Hospice56 (4)41 (4.7)15 (2.9)0.1104
Inpatient death150 (10.8)93 (10.6)57 (11.2)0.7610
Inpatient death > 48 hours after admission122 (8.8)74 (8.5)48 (9.4)0.5529
Inpatient death or hospice206 (14.9)134 (15.3)72 (14.1)0.5365


Write to the Help Desk